Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency
American Journal of Transplantation, 07/27/2012
Zuckermann A et al. – Conversion to sirolimus from calcineurin inhibitor therapy improved renal function in cardiac transplant recipients with renal impairment, but was associated with an attendant acute rejection risk and higher discontinuation rate attributable to adverse events.



